Stocks and Investing Stocks and Investing
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012
Fri, April 20, 2012
Thu, April 19, 2012
Wed, April 18, 2012
[ Wed, Apr 18th 2012 ] - Market Wire
Lac Dore Update
Tue, April 17, 2012

Market Maker Surveillance Report. CMCSA, PFE, BSX, FITB, ACAS, SNY, Highest Net Buy Volume With Lowest Price Friction For Frid


//stocks-investing.news-articles.net/content/201 .. -volume-with-lowest-price-friction-for-frid.html
Published in Stocks and Investing on Friday, April 20th 2012 at 18:01 GMT by WOPRAI   Print publication without navigation


April 20, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 3615 companies with "abnormal" market making, 3565 companies with positive Friction Factors and 2234 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Friday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. COMCAST CORP-CLASS A (NASDAQ:CMCSA), PFIZER INC (NYSE:PFE), BOSTON SCIENTIFIC CORP (NYSE:BSX), FIFTH THIRD BANCORP (NASDAQ:FITB), AMERICAN CAPITAL, LIMITED (NASDAQ:ACAS), SANOFI-AVENTIS-ADR (NYSE:SNY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CMCSA   $0.110    0.37%     7,999,991    58.33%    5,709,430    41.63%    2,290,561    208,233 
  PFE     $0.230    1.01%     11,157,711   29.67%    8,903,370    23.68%    2,254,341    98,015  
  BSX     $0.090    1.54%     5,767,207    33.38%    3,759,774    21.76%    2,007,433    223,048 
  FITB    $0.110    0.83%     9,773,786    56.81%    7,420,049    43.13%    2,353,737    213,976 
  ACAS    $0.210    2.37%     5,606,296    75.59%    1,810,457    24.41%    3,795,839    180,754 
  SNY     $0.500    1.36%     3,655,533    45.90%    1,786,685    22.43%    1,868,848    37,377  
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows CMCSA with a Net Buy Volume of 2,290,561 shares and a Friction Factor of 208,233 shares. That means that it takes 208,233 more shares of buying than selling to move CMCSA higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Friday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

COMCAST CORP-CLASS A (NASDAQ:CMCSA) - Comcast Corporation, together with its subsidiaries, provides consumer entertainment, information, and communication products and services to the residential and commercial customers in the United States. The company operates in two segments, Cable and Programming. The Cable segment manages and operates cable systems, including video, high-speed Internet, and phone services, as well as regional sports and news networks. Its video services include analog, digital, on demand, and high-definition television and/or digital video recorders. This segments high-speed Internet service consists of an interactive portal, Comcast.net, which provides multiple email addresses and online storage, as well as various proprietary content, and value-added features and enhancements. Its phone services include voice over Internet protocol digital phone service that provides local and domestic long-distance calling with various features, such as voice mail, caller ID, and call waiting services. The Programming segment operates national programming networks consisting of E!, The Golf Channel, VERSUS, G4, and Style. The company also develops and operates Internet businesses focused on entertainment, information, and communication, including Comcast.net, Fancast, thePlatform, Fandango, Plaxo, and DailyCandy; and owns two professional sports teams and a multipurpose arena, as well as provides facilities management services, including food services, for sporting events, concerts, and other events. As of December 31, 2009, Comcast Corporation served approximately 23.6 million video customers, 15.9 million high-speed Internet customers, and 7.6 million phone customers, as well as approximately 50.6 million homes in 39 states and the District of Columbia. The company was founded in 1969 and is based in Philadelphia, Pennsylvania.

PFIZER INC (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

BOSTON SCIENTIFIC CORP (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers cardiac rhythm management products, which monitor the heart and deliver electricity to treat cardiac abnormalities; and RF generators, intracardiac ultrasound and steerable ablation catheters, and diagnostic catheters for the diagnosis and treatment of cardiac arrhythmias. The company also provides interventional cardiology products, such as coronary stent systems, coronary revascularization products to treat patients with atherosclerosis and intraluminal catheter-directed ultrasound imaging catheters and systems; vascular access products, balloon catheters, stents and peripheral vascular catheters, wires, and accessories, as well as products for peripheral embolization procedures; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease various forms of benign and malignant tumors. In addition, it offers coated and uncoated detachable coils, micro-delivery stents, micro-guidewires, micro-catheters, guiding catheters, and embolics to neuro-interventional radiologists and neurosurgeons to treat diseases of the neurovascular system; and endoscopy and interventional bronchoscopy products to diagnose and treat various digestive diseases, as well as pulmonary disease systems within the airway and lungs. Further, the company provides urology/womens health products to treat patients with urinary stone disease, benign prostatic hyperplasia, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding; and spinal cord stimulation system for the management of chronic intractable pain of the trunk and/or limbs. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.

FIFTH THIRD BANCORP (NASDAQ:FITB) - Fifth Third Bancorp operates as a diversified financial services holding company. The companys Commercial Banking segment offers banking, cash management, and financial services; traditional lending and depository products and services; and other services, including foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. Its Branch Banking segment provides deposit and loan, and lease products to individuals and corporations. Its products include checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobile and personal financing needs. The companys Consumer Lending segment involves in mortgage and home equity lending activities, such as origination, retention, and servicing of mortgage and home equity loans; and other indirect lending activities, which include loans to consumers through mortgage brokers, automobile dealers, and federal and private student education loans. Its Investment Advisors segment offers investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients, and broker dealer services to the institutional marketplace. This segment also provides asset management services; holistic strategies to affluent clients in wealth planning, investing, insurance, and wealth protection; and advisory services for institutional clients, as well as advises the companys proprietary family of mutual funds. As of December 31, 2009, the company operated 1,309 full-service banking centers, including 103 Bank Mart locations and 2,358 Jeanie ATMs in Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, North Carolina, West Virginia, Pennsylvania, Missouri, and Georgia. The company was founded in 1862 and is headquartered in Cincinnati, Ohio.

AMERICAN CAPITAL, LIMITED (NASDAQ:ACAS) - American Capital, Ltd. is a private equity and venture capital firm specializing in management and employee buyouts, mezzanine, acquisition, recapitalization, middle market, and growth capital investments. The firm seeks to invest in senior debt mezzanine and equity financing for buyouts of private equity firms and direct in private and public companies. It also invests in special situations and in government. In special situations, the firm invests in troubled situations and in distressed situations. In this area, it invests in acquisitions of true turnarounds, 363 auctions, portfolio add-ons, operationally challenged companies; financings in exit, ABL loans, second lien refinance, and direct lending to distressed companies. The firm invests in manufacturing, services, and distribution companies with a special focus on energy sector. In energy production sector, the firm invests in lower risk oil and gas exploration, production and development; natural gas liquids; coal mining and coal-fired generation; uranium mining and nuclear-fired generation; wind-powered generation; and solar-powered generation. In energy transmission sector, the firm invests in oil and gas pipelines; LNG tankers and regasification facilities; and power transmission. In energy distribution sector, it targets propane distribution; gas distribution; electricity distribution. In energy services sector, the firm invests in oil and gas services and utility services. The firm also targets investments in companies that provide services or products to federal, state or local governments. It seeks to invest in information technology, human resources/benefit administration, outsourcing, transaction processing, engineering and construction, logistics, original equipment manufacturers homeland security and component, after market parts and supplies, and technology. It invests as lead or participative investor. The firm and its affiliates invest from $5 million to $300 million per company in North America and 5 million ($6.92520 million) to 25 million ($34.6260 million) per company in Europe. It invests in companies with at least $4 million in EBITDA. American Capital, Ltd. was founded in 1986 and is based in Bethesda, Maryland with additional offices in United States, Europe, and Asia.

SANOFI-AVENTIS-ADR (NYSE:SNY) - Sanofi-Aventis, a healthcare company, engages in the discovery, development, and distribution of therapeutic solutions to improve the lives of everyone. It offers a range of healthcare assets, including a broad-based product portfolio in prescription drugs, OTC/OTX, generics, vaccines, and animal health. The company also has exclusive worldwide license to develop, manufacture, and commercialize antibody drug conjugate (ADC) products for the treatment of cancer. Sanofi-Aventis has a strategic alliance with Scripps Genomic Medicine for the purpose of research and development initiatives in the field of individualized medicine; and with Avila Therapeutics, Inc. to discover targeted covalent drugs for the treatment of cancers, as well as a joint venture with Hangzhou Minsheng Pharmaceutical Group Co. Ltd. to develop non-prescription drugs in China. The company was founded in 1970 and is headquartered in Paris, France.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net


Publication Contributing Sources